NEW YORK, May 6, 2020 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. Food and Drug

Read more here.

Comments

comments

Source: https://blog.ourcrowd.com/dariohealth-self-test-blood-glucose-meters-can-now-be-utilized-within-hospitals-during-the-covid-19-pandemic-per-recently-issued-emergency-fda-guidelines/